The page you were trying to view does not exists or may have expired. Below are the list of similar positions in our database.
Similar Posts
-
Contract Type: Fixed-Term (24 months) /Contract Applications will be reviewed on a rolling basis, with final submission 15 April 2024. Imperial College London and Nanyang Technological University
-
Contract Type: Fixed-Term (24 months) /Contract Expires: 15th April 2024 Applications will be reviewed on a rolling basis, with final submission 15 April 2024. Imperial College London and Nanyang
-
Contract Type: Fixed-Term (24 months) /Contract Expires: 15th April 2024 Applications will be reviewed on a rolling basis, with final submission 15 April 2024. Imperial College London and Nanyang
-
) at Imperial College London, which has been established to address a medical research area of the highest importance and future impact as one of seven new national centres of excellence embedded in major UK
-
and Technology Centre (CR&T) at Imperial College London, which has been established to address a medical research area of the highest importance and future impact as one of seven new national centres
-
Lee Kong Chian School of Medicine (LKCMedicine) established in September 2010 is a partnership between Imperial College London and Nanyang Technological University, Singapore. The school operates
-
. This position is within the UK DRI Care Research and Technology Centre at Imperial College London, which has been established to address a medical research area of the highest importance and future impact as one
-
closely with members of Professor Davies’ & Dr Allsopp’s groups at the NHLI, Royal Brompton campus, Imperial College London. This is a multidisciplinary research team with fundamental science and clinical
-
the heart of West London in the Hammersmith Hospital Campus (W12). The LMS aims to deliver transdisciplinary team science, in synergistic interaction with Imperial College and the wider national research
-
are seeking to appoint a Clinical Research Fellow in Urology to participate in research projects that focuses on novel diagnostic tests and minimally invasive therapies for prostate cancer. The Imperial